ソフトマックス株式会社 2024年12月期第2四半期決算補足説明資料

This document is the supplementary explanation material for the second quarter of the fiscal year ending December 2024 for Soft Max Corporation. It reports on the performance for the interim accounting period ending June 30, 2024, showing a 6.9% increase in sales to 2,330 million yen and a 7.1% increase in operating profit to 182 million yen compared to the same period last year. The growth is attributed to increased demand for medical DX-related systems, including new customer acquisitions and system updates for existing customers. Additionally, government subsidies promoting medical DX initiatives have also had an impact. Overall, steady growth is anticipated.